According to fortune business insights, The global clinical perinatal software market in 2026 size was valued at USD 349.8 million in 2024. The market is projected to grow from USD 375.7 million in 2025 to USD 758.2 million by 2032, exhibiting a CAGR of 10.55% during the forecast period. North America dominated the clinical perinatal software market with a market share of 41.18% in 2024.
The Clinical Perinatal Software Market in 2026 is experiencing robust growth driven by increasing demand for advanced digital health solutions that enhance maternal and fetal care across prenatal, intrapartum, and postnatal stages. This market encompasses integrated software platforms designed to streamline clinical workflows, improve documentation accuracy, support real‑time monitoring, and facilitate evidence‑based decision‑making for obstetricians, midwives, and perinatal care teams. Key factors fueling market expansion include rising awareness of maternal and neonatal health outcomes, growing adoption of electronic health records (EHR) and cloud‑based solutions in healthcare facilities, and a heightened focus on reducing perinatal complications through predictive analytics and interoperability with other clinical systems. Additionally, regulatory emphasis on quality of care, increasing healthcare digitization, and the need for efficient data management solutions are further accelerating investments in perinatal software technologies worldwide.
Continue reading for more details:
https://www.fortunebusinessinsights.com/clinical-perinatal-software-market-114202
The Clinical Perinatal Software Market is segmented across multiple categories to reflect varied user needs and deployment preferences. By type, it includes integrated and standalone solutions, with integrated platforms leading due to seamless data flow, enhanced workflow efficiency, and decision support capabilities. By deployment, the market comprises on-premise and cloud-based offerings, with cloud-based models gaining traction for cost efficiency, scalability, and remote access features. By application, the segments include fetal monitoring, maternal health management, neonatal/infant care, and others, where fetal monitoring remains the dominant segment due to its critical role in detecting complications. By end user, it is split into hospitals & clinics, specialty clinics, and others, with hospitals & clinics accounting for the largest share because they handle most high-risk and neonatal cases requiring software support.
General Electric Company (U.S.)
Koninklijke Philips N.V. (The Netherlands)
PeriGen, Inc. (U.S.)
Clinical Computer Systems, Inc. (U.S.)
Epic Systems (U.S.)
Oracle (U.S.)
System C (UK)
Trium Analysis Online GmbH (Germany)
K2 Medical Systems Ltd. (U.S.)
Huntleigh Healthcare Limited (UK)
The Clinical Perinatal Software Market was valued at approximately USD 349.8 million in 2024 and is projected to grow significantly from USD 375.7 million in 2025 to USD 758.2 million by 2032, registering a robust CAGR of around 10.55% during the forecast period. This growth is driven by increasing digital transformation in healthcare, rising demand for improved maternal and neonatal care, and widespread adoption of electronic health records (EHR), real-time monitoring tools, and clinical decision support systems in obstetrics. Rising maternal and neonatal health complications globally are further propelling adoption of clinical perinatal software solutions that enhance monitoring, risk reduction, and decision-making in perinatal care settings. Clinical Perinatal Software Market expansion is also supported by technological advancements such as cloud-based delivery models and integration with telehealth platforms providing remote care.
Despite strong growth prospects, the Clinical Perinatal Software Market faces several restraints. High implementation and integration costs pose significant barriers, especially for smaller hospitals and clinics and in low- and middle-income regions where IT infrastructure and skilled professionals may be limited. This slows down adoption of advanced perinatal software solutions outside developed healthcare systems. Additionally, limited adoption in emerging economies due to infrastructure gaps and funding constraints further restricts market expansion.
Regionally, North America dominates the Clinical Perinatal Software Market, holding the largest share (over 40% in 2024) and benefitting from strong healthcare digitization, supportive regulatory environments, and high maternal mortality concerns that drive solution adoption. Europe follows with notable growth, aided by rising birth rates and technological advancements, with key markets like the U.K., Germany, and France showing significant uptake. Asia Pacific is expected to grow at a considerable pace, driven by expanding healthcare infrastructure in countries such as China and India, while Latin America and Middle East & Africa are projected to register moderate growth supported by government initiatives promoting digital health adoption in maternal and neonatal care.